Literature DB >> 22552692

Unexplained recurrent miscarriage: how can we explain it?

Sotirios H Saravelos1, Tin-Chiu Li.   

Abstract

Unexplained recurrent miscarriage (RM) can be a challenging and frustrating condition for both patients and clinicians. For the former, there is no diagnosis available for consolation, while for the latter there is little evidence-based treatment to offer. However, the majority of these patients have an excellent prognosis without the need for any treatment. Epidemiological associations suggest that the reason for this is that the majority of women with unexplained RM are in fact healthy individuals, with no underlying pathology, who have suffered three miscarriages purely by chance. Nevertheless, a certain proportion of women with unexplained RM will continue to miscarry, and preliminary studies suggest the presence of pathology in some women of this group. As a result, two types of unexplained RM can be described: Type I unexplained RM, which occurs by chance in women who have no underlying pathology and has a good prognosis; and Type II unexplained RM, which occurs due to an underlying pathology that is currently not yet identified by routine clinical investigations and has a poorer prognosis. Distinguishing between Types I and II unexplained RM can be achieved by considering several factors: the age of the woman, the definition used for RM (i.e. whether biochemical pregnancy losses are considered as miscarriages), the number of previous miscarriages suffered and the karyotype of the products of conception, where available. A better understanding of the two types of unexplained RM could lead to more targeted referrals, investigations and treatments, which would improve cost-effectiveness and overall clinical care.

Entities:  

Mesh:

Year:  2012        PMID: 22552692     DOI: 10.1093/humrep/des102

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

1.  Soluble costimulatory molecule sTim3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion.

Authors:  Mengru Wu; Yuejie Zhu; Jing Zhao; Haiquan Ai; Qiaoqiao Gong; Jia Zhang; Junda Zhao; Qingli Wang; Xiaoling La; Jianbing Ding
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Recurrent pregnancy loss.

Authors:  Evdokia Dimitriadis; Ellen Menkhorst; Shigeru Saito; William H Kutteh; Jan J Brosens
Journal:  Nat Rev Dis Primers       Date:  2020-12-10       Impact factor: 52.329

3.  Correlation between three-dimensional power Doppler and morphometric measurement of endometrial vascularity at the time of embryo implantation in women with unexplained recurrent miscarriage.

Authors:  Xiaoyan Chen; Sotirios H Saravelos; Yingyu Liu; Jin Huang; Chi Chiu Wang; Tin Chiu Li
Journal:  J Mol Histol       Date:  2017-04-27       Impact factor: 2.611

4.  TEAD4 ensures postimplantation development by promoting trophoblast self-renewal: An implication in early human pregnancy loss.

Authors:  Biswarup Saha; Avishek Ganguly; Pratik Home; Bhaswati Bhattacharya; Soma Ray; Ananya Ghosh; M A Karim Rumi; Courtney Marsh; Valerie A French; Sumedha Gunewardena; Soumen Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-15       Impact factor: 11.205

Review 5.  Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss.

Authors:  Luis Alejandro Arias-Sosa; Iván Darío Acosta; Elkin Lucena-Quevedo; Harold Moreno-Ortiz; Clara Esteban-Pérez; Maribel Forero-Castro
Journal:  J Assist Reprod Genet       Date:  2018-01-09       Impact factor: 3.412

6.  Placental C4d as a common feature of chromosomally normal and abnormal miscarriages.

Authors:  Joong Yeup Lee; Joon-Seok Hong; Eun Na Kim; Soyeon Ahn; Jin Choe; Doyeong Hwang; Ki Chul Kim; Seok Hyun Kim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2014-03-27       Impact factor: 4.064

Review 7.  GATA factors: Master regulators of gene expression in trophoblast progenitors.

Authors:  Soumen Paul; Pratik Home; Bhaswati Bhattacharya; Soma Ray
Journal:  Placenta       Date:  2017-05-10       Impact factor: 3.481

Review 8.  The T helper type 17/regulatory T cell paradigm in pregnancy.

Authors:  Ana Sofia Figueiredo; Anne Schumacher
Journal:  Immunology       Date:  2016-05       Impact factor: 7.397

Review 9.  Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice?

Authors:  Adel Abu-Heija
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

10.  Luteal phase support for documented failure of placental steroidogenesis: A case report.

Authors:  Bryan Kratz; Amer Rasheed; John P Holden
Journal:  Case Rep Womens Health       Date:  2016-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.